Galicia is one of the strongest biotechnological powers in Spain both at business and research levels.
The constant transfer of knowledge to companies primarily comes from the extensive research experience of its three Universities (A Coruña, Santiago de Compostela and Vigo) with their two Campuses of Excellence, as well as from its Public Health System (SERGAS).
Galician academic research has built a reputation through its position in various international rankings as one of the leaders in scientific production and for the quality of its research. All of this provides the region with valuable Know-how which has been moved towards the market and increased its value in the last few years with the setting up of numerous spin-off companies, throughout the world which today are commercializing
the results of the research carried out.
In 2015, Galicia became the sixth most important autonomous region with regard to biotechnology user companies, with 7.34% of the national total, i.e. 201 companies.
With regard to the geographic distribution of biotechnological companies for 2015, Galicia represents 4.39% of the national total according to INE’s information, highlighting the increase in the creation of companies in the past years and placing the Galician region amongst the first on the list for biotech production.
The majority of the companies in the biotech sector show a medium-length business development, around seven years of activity, meaning that it is a sector in a state of strong growth which is highly specialized and innovative.
A differentiating factor is the close cooperation with research groups, who position themselves as principal partners.
As a result of all these characteristics, we can highlight the different advantages of the biotech sector in Galicia:
• Existing training offers and the availability of highly qualified human resources
• The existence of research centres, institutes and groups of renowned quality at national and international level
• The dynamics in certain traditional business and industrial sectors which use
biotechnology to increase the value of their products and services
• The availability of various institutional research support schemes, development, innovation, science, technology and entrepreneurship
• Entrepreneurial culture